Some studies have shown that EGFR mutations are a better prognostic predictor in cases of operable non-small cell lung cancer [9,14], while others have revealed no significant impact of EGFR mutations [16,35,37]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.